Consolidated Balance Sheet

30 KB EXCEL

 
€ million Note Dec. 31, 2017 Dec. 31, 2016
Non-current assets1
Goodwill1 ➞ 16 13,582 15,015
Other intangible assets1 ➞ 17 8,317 9,980
Property, plant and equipment1 ➞ 18 4,512 4,231
Non-current financial assets ➞ 19 444 218
Other non-current assets ➞ 20 205 131
Deferred tax assets ➞ 14 1,106 1,013
28,166 30,589
Current assets1
Inventories1 ➞ 21 2,632 2,609
Trade accounts receivable ➞ 22 2,923 2,889
Current financial assets ➞ 19 90 145
Other current assets1 ➞ 20 731 672
Income tax receivables ➞ 23 490 403
Cash and cash equivalents ➞ 24 589 939
Assets held for sale ➞ 4 12
7,455 7,670
Total assets1 35,621 38,258
     
Total equity ➞ 25
Equity capital 565 565
Reserves 12,357 10,362
Gains/losses recognized in equity 1,082 3,062
Equity attributable to Merck KGaA shareholders 14,003 13,989
Non-controlling interests 63 61
14,066 14,050
Non-current liabilities1
Provisions for pensions and other post-employment benefits ➞ 26 2,257 2,313
Other non-current provisions ➞ 27 788 834
Non-current financial liabilities ➞ 28 8,033 8,809
Other non-current liabilities ➞ 29 354 439
Deferred tax liabilities1 ➞ 14 1,489 2,724
12,919 15,119
Current liabilities1
Current provisions ➞ 27 414 412
Current financial liabilities ➞ 28 2,790 3,788
Trade accounts payable ➞ 30 2,195 2,048
Income tax liabilities ➞ 31 1,059 883
Other current liabilities1 ➞ 29 2,175 1,950
Liabilities directly related to assets held for sale ➞ 4 8
8,635 9,089
Total equity and liabilities1 35,621 38,258
1
Previous year’s figures have been adjusted, see Note (4) ‟Acquisitions and divestments”.